A citation-based method for searching scientific literature

Mauren K Tavares, Suellen Dos Reis, Nicolle Platt, Isabella A Heinrich, Ingrid A V Wolin, Rodrigo B Leal, Manuella P Kaster, Ana Lúcia S Rodrigues, Andiara E Freitas. Neurochem Int 2018
Times Cited: 9







List of co-cited articles
64 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.
Nanxin Li, Boyoung Lee, Rong-Jian Liu, Mounira Banasr, Jason M Dwyer, Masaaki Iwata, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Science 2010
55

Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling.
Vivian Binder Neis, Morgana Moretti, Luis Eduardo B Bettio, Camille M Ribeiro, Priscila Batista Rosa, Filipe Marques Gonçalves, Mark William Lopes, Rodrigo Bainy Leal, Ana Lúcia S Rodrigues. Eur Neuropsychopharmacol 2016
32
55

Single administration of agmatine reverses the depressive-like behavior induced by corticosterone in mice: Comparison with ketamine and fluoxetine.
Vivian B Neis, Luis B Bettio, Morgana Moretti, Priscila B Rosa, Gislaine Olescowicz, Daiane B Fraga, Filipe M Gonçalves, Andiara E Freitas, Isabella A Heinrich, Mark W Lopes,[...]. Pharmacol Biochem Behav 2018
13
44

Regional localization of agmatine in the rat brain: an immunocytochemical study.
K Otake, D A Ruggiero, S Regunathan, H Wang, T A Milner, D J Reis. Brain Res 1998
114
44

Acute agmatine administration, similar to ketamine, reverses depressive-like behavior induced by chronic unpredictable stress in mice.
Vivian B Neis, Luis E B Bettio, Morgana Moretti, Priscila B Rosa, Camille M Ribeiro, Andiara E Freitas, Filipe M Gonçalves, Rodrigo B Leal, Ana Lúcia S Rodrigues. Pharmacol Biochem Behav 2016
27
44

Therapeutic potential of agmatine for CNS disorders.
Vivian B Neis, Priscila B Rosa, Gislaine Olescowicz, Ana Lúcia S Rodrigues. Neurochem Int 2017
19
44

Agmatine produces antidepressant-like effects in two models of depression in mice.
Andrea D E Zomkowski, Luciana Hammes, Jaime Lin, João Batista Calixto, Adair Roberto S Santos, Ana Lúcia S Rodrigues. Neuroreport 2002
142
44

Agmatine enhances antidepressant potency of MK-801 and conventional antidepressants in mice.
Vivian Binder Neis, Morgana Moretti, Luana Meller Manosso, Mark W Lopes, Rodrigo Bainy Leal, Ana Lúcia S Rodrigues. Pharmacol Biochem Behav 2015
27
33

Depressive-like behavior induced by tumor necrosis factor-α is abolished by agmatine administration.
Vivian Binder Neis, Luana Meller Manosso, Morgana Moretti, Andiara E Freitas, Juliana Daufenbach, Ana Lúcia S Rodrigues. Behav Brain Res 2014
45
33

Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in Mice.
Andiara E Freitas, Javier Egea, Izaskun Buendia, Vanessa Gómez-Rangel, Esther Parada, Elisa Navarro, Ana Isabel Casas, Aneta Wojnicz, José Avendaño Ortiz, Antonio Cuadrado,[...]. Mol Neurobiol 2016
57
33

Agmatine abolishes restraint stress-induced depressive-like behavior and hippocampal antioxidant imbalance in mice.
Andiara E Freitas, Luis E B Bettio, Vivian B Neis, Danúbia B Santos, Camille M Ribeiro, Priscila B Rosa, Marcelo Farina, Ana Lúcia S Rodrigues. Prog Neuropsychopharmacol Biol Psychiatry 2014
65
33


Agmatine crosses the blood-brain barrier.
J E Piletz, P J May, G Wang, H Zhu. Ann N Y Acad Sci 2003
53
33

Agmatine attenuates chronic unpredictable mild stress-induced anxiety, depression-like behaviours and cognitive impairment by modulating nitrergic signalling pathway.
Nitin B Gawali, Vipin D Bulani, Malvika S Gursahani, Padmini S Deshpande, Pankaj S Kothavade, Archana R Juvekar. Brain Res 2017
34
33

Effects of Agmatine on Depressive-Like Behavior Induced by Intracerebroventricular Administration of 1-Methyl-4-phenylpyridinium (MPP(+)).
Morgana Moretti, Vivian Binder Neis, Filipe Carvalho Matheus, Mauricio Peña Cunha, Priscila Batista Rosa, Camille Mertins Ribeiro, Ana Lúcia S Rodrigues, Rui Daniel Prediger. Neurotox Res 2015
31
33


Involvement of the agmatinergic system in the depressive-like phenotype of the Crtc1 knockout mouse model of depression.
E M Meylan, L Breuillaud, T Seredenina, P J Magistretti, O Halfon, R Luthi-Carter, J-R Cardinaux. Transl Psychiatry 2016
32
33


Agmatine induces Nrf2 and protects against corticosterone effects in hippocampal neuronal cell line.
Andiara E Freitas, Javier Egea, Izaskun Buendía, Elisa Navarro, Patricia Rada, Antonio Cuadrado, Ana Lúcia S Rodrigues, Manuela G López. Mol Neurobiol 2015
35
33

Agmatine, a potential novel therapeutic strategy for depression.
Andiara E Freitas, Vivian B Neis, Ana Lúcia S Rodrigues. Eur Neuropsychopharmacol 2016
24
33

Sub-chronic agmatine treatment modulates hippocampal neuroplasticity and cell survival signaling pathways in mice.
Andiara E Freitas, Luis E B Bettio, Vivian B Neis, Morgana Moretti, Camille M Ribeiro, Mark W Lopes, Rodrigo B Leal, Ana Lúcia S Rodrigues. J Psychiatr Res 2014
24
33

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, Nancy E Brutsche, Rezvan Ameli, David A Luckenbaugh, Dennis S Charney, Husseini K Manji. Arch Gen Psychiatry 2006
33

Antidepressant effects of ketamine in depressed patients.
R M Berman, A Cappiello, A Anand, D A Oren, G R Heninger, D S Charney, J H Krystal. Biol Psychiatry 2000
33

Creatine, Similar to Ketamine, Counteracts Depressive-Like Behavior Induced by Corticosterone via PI3K/Akt/mTOR Pathway.
Francis L Pazini, Mauricio P Cunha, Julia M Rosa, André R S Colla, Vicente Lieberknecht, Ágatha Oliveira, Ana Lúcia S Rodrigues. Mol Neurobiol 2016
69
33


Protective effects of agmatine on lipopolysaccharide-injured microglia and inducible nitric oxide synthase activity.
Soo Kyung Ahn, Samin Hong, Yu Mi Park, Ja Yong Choi, Won Taek Lee, Kyung Ah Park, Jong Eun Lee. Life Sci 2012
30
22

HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition.
J Keller, R Gomez, G Williams, A Lembke, L Lazzeroni, G M Murphy, A F Schatzberg. Mol Psychiatry 2017
186
22

Agmatine enhances neurogenesis by increasing ERK1/2 expression, and suppresses astrogenesis by decreasing BMP 2,4 and SMAD 1,5,8 expression in subventricular zone neural stem cells.
Ho Won Song, Bokara Kiran Kumar, Sa Hyun Kim, Yong Heui Jeon, Yoon Azalea Lee, Won Teak Lee, Kyung Ah Park, Jong Eun Lee. Life Sci 2011
21
22


Effects of agmatine on hypoxic microglia and activity of nitric oxide synthase.
Soo Kyung Ahn, Samin Hong, Yu Mi Park, Won Taek Lee, Kyung Ah Park, Jong Eun Lee. Brain Res 2011
26
22



Antidepressant and pro-neurogenic effects of agmatine in a mouse model of stress induced by chronic exposure to corticosterone.
Gislaine Olescowicz, Vivian B Neis, Daiane B Fraga, Priscila B Rosa, Dayane P Azevedo, Fernando Falkenburger Melleu, Patricia S Brocardo, Joana Gil-Mohapel, Ana Lúcia S Rodrigues. Prog Neuropsychopharmacol Biol Psychiatry 2018
23
22

Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment.
Zhen Ren, Horia Pribiag, Sarah J Jefferson, Matthew Shorey, Thomas Fuchs, David Stellwagen, Bernhard Luscher. Biol Psychiatry 2016
53
22

Agmatine attenuates brain edema through reducing the expression of aquaporin-1 after cerebral ischemia.
Jae Hwan Kim, Yong Woo Lee, Kyung Ah Park, Won Taek Lee, Jong Eun Lee. J Cereb Blood Flow Metab 2010
42
22

Agmatine ameliorates lipopolysaccharide induced depressive-like behaviour in mice by targeting the underlying inflammatory and oxido-nitrosative mediators.
Nitin B Gawali, Vipin D Bulani, Amrita A Chowdhury, Padmini S Deshpande, Dnyaneshwar M Nagmoti, Archana R Juvekar. Pharmacol Biochem Behav 2016
40
22

Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide Y.
B G Taksande, N R Kotagale, K T Nakhate, P D Mali, D M Kokare, K Hirani, N K Subhedar, C T Chopde, R R Ugale. Br J Pharmacol 2011
32
22

Agmatine prevents LPS-induced spatial memory impairment and hippocampal apoptosis.
Asadollah Zarifkar, Samira Choopani, Rasoul Ghasemi, Nasser Naghdi, Amir Hossein Maghsoudi, Nader Maghsoudi, Karim Rastegar, Maryam Moosavi. Eur J Pharmacol 2010
70
22

Agmatine protects against intracerebroventricular streptozotocin-induced water maze memory deficit, hippocampal apoptosis and Akt/GSK3β signaling disruption.
Maryam Moosavi, Amir Hossein Zarifkar, Yaghoub Farbood, Mahin Dianat, Alireza Sarkaki, Rasoul Ghasemi. Eur J Pharmacol 2014
26
22

Agmatine attenuates lipopolysaccharide induced anorexia and sickness behavior in rats.
Brijesh G Taksande, Chandrabhan T Chopde, Milind J Umekar, Nandkishor R Kotagale. Pharmacol Biochem Behav 2015
13
22

Effects of agmatine on blood-brain barrier stabilization assessed by permeability MRI in a rat model of transient cerebral ischemia.
S S Ahn, S H Kim, J E Lee, K J Ahn, D J Kim, H S Choi, J Kim, N-Y Shin, S-K Lee. AJNR Am J Neuroradiol 2015
9
22

Evidence for imidazoline receptors involvement in the agmatine antidepressant-like effect in the forced swimming test.
Mariana P Zeidan, Andréa D E Zomkowski, Angelo O Rosa, Ana Lúcia S Rodrigues, Nelson H Gabilan. Eur J Pharmacol 2007
42
22

Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature.
A J Ferrari, A J Somerville, A J Baxter, R Norman, S B Patten, T Vos, H A Whiteford. Psychol Med 2013
457
22

The Role of Neural Plasticity in Depression: From Hippocampus to Prefrontal Cortex.
Wei Liu, Tongtong Ge, Yashu Leng, Zhenxiang Pan, Jie Fan, Wei Yang, Ranji Cui. Neural Plast 2017
180
22

Acute orexigenic effect of agmatine involves interaction between central α2-adrenergic and GABAergic receptors.
Brijesh Gulabrao Taksande, Omi Sharma, Manish Manohar Aglawe, Mayur Bhimrao Kale, Dinesh Yugraj Gawande, Milind Janraoji Umekar, Nandkishor Ramdas Kotagale. Biomed Pharmacother 2017
2
100

Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor.
G Olmos, N DeGregorio-Rocasolano, M Paz Regalado, T Gasull, M Assumpció Boronat, R Trullas, A Villarroel, J Lerma, J A García-Sevilla. Br J Pharmacol 1999
138
22

Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons.
Wei-Ping Wang, Abiye H Iyo, Javier Miguel-Hidalgo, Soundar Regunathan, Meng-Yang Zhu. Brain Res 2006
80
22

Metabolic strategies for the degradation of the neuromodulator agmatine in mammals.
José Benítez, David García, Nicol Romero, Arlette González, José Martínez-Oyanedel, Maximiliano Figueroa, Mónica Salas, Vasthi López, María García-Robles, Peter R Dodd,[...]. Metabolism 2018
12
22

The antidepressant-like effect of chronic guanosine treatment is associated with increased hippocampal neuronal differentiation.
Luis E B Bettio, Vivian B Neis, Francis L Pazini, Patricia S Brocardo, Anna R Patten, Joana Gil-Mohapel, Brian R Christie, Ana Lúcia S Rodrigues. Eur J Neurosci 2016
23
22

Agmatine: clinical applications after 100 years in translation.
John E Piletz, Feyza Aricioglu, Juei-Tang Cheng, Carolyn A Fairbanks, Varda H Gilad, Britta Haenisch, Angelos Halaris, Samin Hong, Jong Eun Lee, Jin Li,[...]. Drug Discov Today 2013
129
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.